NF-kappaB activation in peripheral blood monocytes/macrophages and T cells during acute Kawasaki disease
- PMID: 11358434
- DOI: 10.1006/clim.2001.5026
NF-kappaB activation in peripheral blood monocytes/macrophages and T cells during acute Kawasaki disease
Abstract
Kawasaki disease (KD) is a febrile disease of childhood characterized by systemic vasculitis, and the levels of many proinflammatory cytokines are elevated in the serum at the acute stage. We investigated the activation of transcription factor NF-kappaB for genes that encode the proinflammatory cytokines in CD14+ monocytes/macrophages and CD3+ T cells in peripheral blood by means of Western blot and flow cytometric analyses. Western blot analysis demonstrated that NF-kappaB activation was more increased in CD14+ monocytes/macrophages than in CD3+ T cells in all children during the acute stage. Flow cytometric analysis revealed that NF-kappaB activation in CD14+ monocytes/macrophages was significantly higher than in CD3+ T cells at the acute stage (30.0 +/- 16.0% vs 11.4 +/- 5.0%, P < 0.01, Wilcoxon test). NF-kappaB activation in CD14+ monocytes/macrophages was significantly decreased after high-dose intravenous immunoglobulin therapy (P < 0.05). The present findings suggest that CD14+ monocytes/macrophages play an important role in cytokine production during acute KD.
Copyright 2001 Academic Press.
Similar articles
-
Intravenous immunoglobulin does not increase FcgammaRIIB expression on monocytes/macrophages during acute Kawasaki disease.Rheumatology (Oxford). 2005 Mar;44(3):314-7. doi: 10.1093/rheumatology/keh488. Epub 2004 Nov 30. Rheumatology (Oxford). 2005. PMID: 15572393
-
Expression of Toll-like receptor 2 on CD16+ blood monocytes and synovial tissue macrophages in rheumatoid arthritis.Arthritis Rheum. 2004 May;50(5):1457-67. doi: 10.1002/art.20219. Arthritis Rheum. 2004. PMID: 15146415
-
[Regulation of proinflammatory cytokine cascade in Kawasaki disease].Nihon Rinsho. 2008 Feb;66(2):258-64. Nihon Rinsho. 2008. PMID: 18260323 Review. Japanese.
-
Intravenous immunoglobulin inhibits NF-kappaB activation and affects Fcgamma receptor expression in monocytes/macrophages.Naunyn Schmiedebergs Arch Pharmacol. 2004 Apr;369(4):428-33. doi: 10.1007/s00210-004-0877-x. Epub 2004 Feb 25. Naunyn Schmiedebergs Arch Pharmacol. 2004. PMID: 14985941
-
Clinical and immunologic aspects of Kawasaki disease.Immunodefic Rev. 1989;1(3):261-71. Immunodefic Rev. 1989. PMID: 2698643 Review.
Cited by
-
Utility of Soluble CD163 in the Clinical Management of Patients With Kawasaki Disease.Front Pediatr. 2020 Apr 7;8:148. doi: 10.3389/fped.2020.00148. eCollection 2020. Front Pediatr. 2020. PMID: 32318530 Free PMC article.
-
Correlation between NF-κB signal pathway-mediated caspase-4 activation and Kawasaki disease.Exp Ther Med. 2017 Jun;13(6):3333-3336. doi: 10.3892/etm.2017.4409. Epub 2017 Apr 28. Exp Ther Med. 2017. PMID: 28587409 Free PMC article.
-
Understanding the pathogenesis of Kawasaki disease by network and pathway analysis.Comput Math Methods Med. 2013;2013:989307. doi: 10.1155/2013/989307. Epub 2013 Mar 6. Comput Math Methods Med. 2013. PMID: 23533546 Free PMC article. Review.
-
Unique activation status of peripheral blood mononuclear cells at acute phase of Kawasaki disease.Clin Exp Immunol. 2010 May;160(2):246-55. doi: 10.1111/j.1365-2249.2009.04073.x. Epub 2009 Dec 15. Clin Exp Immunol. 2010. PMID: 20015095 Free PMC article.
-
Anti-inflammatory effect of intravenous immunoglobulin in comparison with dexamethasone in vitro: implication for treatment of Kawasaki disease.Naunyn Schmiedebergs Arch Pharmacol. 2006 Aug;373(5):325-32. doi: 10.1007/s00210-006-0084-z. Epub 2006 Aug 1. Naunyn Schmiedebergs Arch Pharmacol. 2006. PMID: 16896803
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials